bone and mineral homeostasis agents Flashcards
Aspirin MOA
acetylation of COX-1 & COX-2, dec. in prostaglandin synthesis
Aspirin AE
GI toxicity, nephrotoxicity, inc. bleeding time, hypersensitivity, coma in overdose
Ibuprofen MOA
reversible inhibition of COX-1 & COX-2, dec. in prostaglandin synthesis
Ibuprofen AE
GI toxicity, nephrotoxicity, hypersensitivity
Celecoxib MOA
selective reversible inhibition of COX-2, dec. in prostaglandin synthesis
Celecoxib AE
nephrotoxicity, hypersensitivity, less GI toxicity, greater risk of thrombosis
Acetaminophen MOA
weak COX inhibitor
Acetaminophen AE
hepatotoxicity
Methotrexate MOA
cytotoxic to rapid dividing immune cells d/t inhibition if dihydrofolate reductase
Methotrexate AE
nausea, mucosal ulcers, hematotoxicity, hepatotoxicity, teratogenicity
Colchicine MOA
inhibition of microtubule assembly and LTB4 production; dec. macrophages migration
Colchicine AE
diarrhea, severe liver and kidney damage
Probenecid MOA
inhibition of renal reuptake of UA in proximal rubule
Probenecid AE
exacerbation of acute gout (prevent by co-ad w/ colchicine or indomethacin)
Allopurinol MOA
active metabolite irreversibly inhibits xanthine oxidase and lowers production of UA
Allopurinol AE
GI upset, hypersensitivity, BM suppression
Drug used in mgmt of jRA but not in GA since it prevents excretion of UA
aspirin
associated with reye sundrome
aspirin
antidote to paracetamol overdose
N-acetylcysteine
toxic dose and lethal dose of paracetamol
t: 150mg/kg (21x500mg tabs)
l: 15g (30x500mg tabs)
drug that inhibit secretion of other weak acids
probenecid
first line for chronic gout
allopurinol